Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

NCT04889742 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT04889742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04889742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors
Lead sponsor
Charite University, Berlin, Germany
Phase
Phase 2
Overall status
Not yet recruiting
Start date
May 10, 2024
Completion date
January 31, 2028
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, cervical cancer, esophageal cancer, neuroendocrine tumors, pancreas cancer, prostate cancer, rectal cancer, recurrent cancer, sarcoma, squamous cell carcinoma